Whitepaper: Ensure accurate dose prediction for clinical trials

Mouse in laboratory

Accurate dose prediction for clinical trials is essential to ensure patient safety and trial success.

This new whitepaper from the Jackson Laboratory discusses evidence-based selection of starting doses in first-in-human clinical trials through the utilisation of humanised mouse models.

In this whitepaper you will learn about:

  • The significance of selecting appropriate starting doses in clinical trials.
  • Utilising humanised mouse models to mimic human responses.
  • Integration of preclinical data and physiological parameters for dose prediction.
  • Advantages of refining dosing strategies, minimising risks, and improving trial outcomes.
  • Enhancing understanding of drug behaviour, toxicity, and efficacy in humans.
  • The potential to revolutionise drug development by optimising dose selection.

Download the whitepaper for free.

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free